A patient has received three clinic doses of omalizumab. He has a documented history of idiopathic anaphylaxis, missed dose 4 and asks the pharmacy

Question

A patient has received three clinic doses of omalizumab. He has a documented history of idiopathic anaphylaxis, missed dose 4 and asks the pharmacy to supply a pen for home use; injection training is recorded but no physician has authorised self-injection. What is the most appropriate action?

Accepted Answer

Refer to the specialist service for a supervised missed-dose and administration plan

Answer

Ask the patient to omit this dose and attend the next appointment without contacting the service

Answer

Provide injection training today, supply the pen and notify the specialist after administration

Answer

Supply half the prescribed dose now and release the remainder after specialist authorisation

Answer

Supply one dose if a family member observes, then ask the specialist to authorise future doses

Biologic asthma supply — GPhC CRA MCQ

A patient has received three clinic doses of omalizumab. He has a documented history of idiopathic anaphylaxis, missed dose 4 and asks the pharmacy to supply a pen for home use; injection training is recorded but no physician has authorised self-injection. What is the most appropriate action?